Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium.

Abstract

Ovarian cancer is a disease of older women. However, the molecular mechanisms of ovarian aging and their contribution to the pathogenesis of ovarian cancer are currently unclear. mTOR signalling is a major regulator of aging as suppression of this pathway extends lifespan in model organisms. Overactive mTOR signalling is present in up to 80% of ovarian cancer samples and is associated with poor prognosis. This study examined the role of mTOR signalling in age-associated changes in ovarian surface epithelium (OSE). Histological examination of ovaries from both aged mice and women revealed OSE cell hyperplasia, papillary growth and inclusion cysts. These pathological lesions expressed bonafide markers of ovarian cancer precursor lesions, Pax8 and Stathmin 1, and were presented with elevated mTOR signalling. To understand whether overactive mTOR signalling is responsible for the development of these pathological changes, we analysed ovaries of the Pten trangenic mice and found significant reduction in OSE lesions compared to controls. Furthermore, pharmacological suppression of mTOR signalling significantly decreased OSE hyperplasia in aged mice. Treatment with mTOR inhibitors reduced human ovarian cancer cell viability, proliferation and colony forming ability. Collectively, we have established the role of mTOR signalling in age-related OSE pathologies and initiation of ovarian cancer.

• Authors: Preety Bajwa, Prathima B Nagendra, Sarah Nielsen, Subhransu S Sahoo, Amanda Bielanowicz, Janine M Lombard, J Erby Wilkinson, Richard A Miller, Pradeep S Tanwar
• Journal: Oncotarget (Oncotarget) Vol. 7 Issue 15 Pg. 19214-27 (Apr 12 2016) ISSN: 1949-2553 [Electronic] United States
• PMID: 27036037 (Publication Type: Journal Article)

Chemical References

• Immunosuppressive Agents
• TOR Serine-Threonine Kinases
• PTEN Phosphohydrolase
• Sirolimus

Topics

• Aging
• Animals
• Blotting, Western
• Cell Line, Tumor
• Cell Survival (drug effects)
• Epithelial Cells (drug effects, metabolism)
• Epithelium (drug effects, metabolism, pathology)
• Female
• Humans
• Hyperplasia (metabolism, prevention & control)
• Immunosuppressive Agents (pharmacology)
• Mice, Inbred C57BL
• Mice, Transgenic
• Ovary (metabolism, pathology)
• PTEN Phosphohydrolase (genetics, metabolism)
• Sirolimus (pharmacology)
• TOR Serine-Threonine Kinases (metabolism)